{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:58:20Z","timestamp":1781805500247,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Psychology of the University of Canterbury"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.neulet.2018.02.025","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T17:41:22Z","timestamp":1518543682000},"page":"88-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Replacement treatment during extinction training with the atypical dopamine uptake inhibitor, JHW-007, reduces relapse to methamphetamine seeking"],"prefix":"10.1016","volume":"671","author":[{"given":"Ashlea F.","family":"Dassanayake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Canales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2018.02.025_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","article-title":"Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings","volume":"129","author":"Panenka","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neulet.2018.02.025_bib0010","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.neulet.2018.02.025_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0025","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1074\/jbc.M805298200","article-title":"Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo","volume":"284","author":"Goodwin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2018.02.025_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.02.025_bib0035","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2011.86","article-title":"Decreased dopamine activity predicts relapse in methamphetamine abusers","volume":"17","author":"Wang","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neulet.2018.02.025_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","article-title":"Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis","volume":"74","author":"Ashok","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neulet.2018.02.025_bib0045","first-page":"CD000146","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neulet.2018.02.025_bib0050","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neulet.2018.02.025_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","article-title":"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction","volume":"75","author":"Rothman","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.103.053504","article-title":"Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques","volume":"307","author":"Raje","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.02.025_bib0080","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2018.02.025_bib0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pnpbp.2013.01.016","article-title":"The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens","volume":"44","author":"Velazquez-Sanchez","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.02.025_bib0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2014.03.015","article-title":"Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker","volume":"731","author":"Ferragud","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.113.208264","article-title":"Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats","volume":"348","author":"Hiranita","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1369-1600.2012.00458.x","article-title":"Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking","volume":"18","author":"Velazquez-Sanchez","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2010.09.032","article-title":"Mirtazapine alters cue-associated methamphetamine seeking in rats","volume":"69","author":"Graves","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.02.025_bib0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pbb.2012.06.011","article-title":"Chronic treatment with curcumin enhances methamphetamine locomotor sensitization and cue-induced reinstatement of methamphetamine self-administration","volume":"102","author":"Zhao","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2018.02.025_bib0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-009-1653-x","article-title":"A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat","volume":"207","author":"Ferragud","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2018.02.025_bib0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1139\/jpn.0635","article-title":"The need for speed: an update on methamphetamine addiction","volume":"31","author":"Barr","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neulet.2018.02.025_bib0130","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm00041a002","article-title":"Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles","volume":"37","author":"Newman","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2018.02.025_bib0135","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2018.02.025_bib0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.110.173260","article-title":"N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects","volume":"336","author":"Li","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0145","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2018.02.025_bib0150","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/prot.21598","article-title":"Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template","volume":"70","author":"Indarte","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.neulet.2018.02.025_bib0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2010.08.021","article-title":"The binding sites for benztropines and dopamine in the dopamine transporter overlap","volume":"60","author":"Bisgaard","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2018.02.025_bib0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.110.171629","article-title":"Dopamine transporter-dependent and \u2212independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability","volume":"335","author":"Kopajtic","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.euroneuro.2010.03.005","article-title":"The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization","volume":"20","author":"Velazquez-Sanchez","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2018.02.025_bib0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.109.155770","article-title":"Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion","volume":"331","author":"Schwendt","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245475","article-title":"A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action","volume":"109","author":"Marek","year":"1992","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2018.02.025_bib0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002512-199404040-00006","article-title":"Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders","volume":"4","author":"Haria","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neulet.2018.02.025_bib0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0091-3057(01)00669-4","article-title":"Serotonin releasing agents neurochemical, therapeutic and adverse effects","volume":"71","author":"Rothman","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2018.02.025_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","article-title":"Antidepressant activity of curcumin: involvement of serotonin and dopamine system","volume":"201","author":"Kulkarni","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2018.02.025_bib0195","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/npp.2012.29","article-title":"Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use","volume":"37","author":"Sawyer","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2018.02.025_bib0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00213-002-1307-8","article-title":"Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats","volume":"168","author":"Burmeister","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2018.02.025_bib0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.110.169417","article-title":"Sustained administration of trazodone enhances serotonergic neurotransmission: in vivo electrophysiological study in the rat brain","volume":"335","author":"Ghanbari","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2018.02.025_bib0210","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00213-004-2095-0","article-title":"Effects of the antidepressant trazodone, a 5-HT 2A\/2C receptor antagonist, on dopamine-dependent behaviors in rats","volume":"179","author":"Balsara","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neulet.2018.02.025_bib0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/1043-6618(94)80002-2","article-title":"Effects of acute and chronic treatment with trazodone, an antidepressant, on the sleep-wake activity in rats","volume":"30","author":"Lelkes","year":"1994","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neulet.2018.02.025_bib0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0091-3057(01)00636-0","article-title":"Chronic stress impairs rotarod performance in rats: implications for depressive state","volume":"71","author":"Mizoguchi","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2018.02.025_bib0225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drugalcdep.2011.04.015","article-title":"Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine","volume":"118","author":"Zorick","year":"2011","journal-title":"Drug Alcohol Depend."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394018301010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394018301010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:21:54Z","timestamp":1759609314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394018301010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":45,"alternative-id":["S0304394018301010"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2018.02.025","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replacement treatment during extinction training with the atypical dopamine uptake inhibitor, JHW-007, reduces relapse to methamphetamine seeking","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2018.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}